[
  {
    "title": "Odkaz: ca.news.yahoo.com",
    "sourceUrl": "https://ca.news.yahoo.com/ozempic-teeth-dentists-warn-glp-184445013.html",
    "summaryUrl": "https://ca.news.yahoo.com/ozempic-teeth-dentists-warn-glp-184445013.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: biospace.com",
    "sourceUrl": "https://www.biospace.com/drug-development/weight-loss-wasteland-5-obesity-assets-that-failed",
    "summaryUrl": "https://www.biospace.com/drug-development/weight-loss-wasteland-5-obesity-assets-that-failed",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: wane.com",
    "sourceUrl": "https://www.wane.com/news/ozempic-teeth-dentists-warn-of-new-glp-1-side-effect/",
    "summaryUrl": "https://www.wane.com/news/ozempic-teeth-dentists-warn-of-new-glp-1-side-effect/",
    "date": "2025-08-26"
  },
  {
    "title": "PressReader.com - Digital Newspaper & Magazine Subscriptions",
    "sourceUrl": "https://www.pressreader.com/usa/the-washington-post-sunday-598/20250824/281904484282452",
    "summaryUrl": "https://www.pressreader.com/usa/the-washington-post-sunday-598/20250824/281904484282452",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: ibtimes.co.uk",
    "sourceUrl": "https://www.ibtimes.co.uk/uk-sales-wegovy-skyrocket-2000-dieters-dump-mounjaro-after-170-price-hike-1742037",
    "summaryUrl": "https://www.ibtimes.co.uk/uk-sales-wegovy-skyrocket-2000-dieters-dump-mounjaro-after-170-price-hike-1742037",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: womenshealthmag.com",
    "sourceUrl": "https://www.womenshealthmag.com/uk/fitness/fat-loss/a65862142/serena-williams-weight-loss-glp1-ro/",
    "summaryUrl": "https://www.womenshealthmag.com/uk/fitness/fat-loss/a65862142/serena-williams-weight-loss-glp1-ro/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: today.com",
    "sourceUrl": "https://www.today.com/health/womens-health/serena-williams-glp-1-weight-loss-rcna226141",
    "summaryUrl": "https://www.today.com/health/womens-health/serena-williams-glp-1-weight-loss-rcna226141",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rheumatologyadvisor.com",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/26-5-percent-of-adults-with-diabetes-used-glp-1-ra-injectables-in-2024/",
    "summaryUrl": "https://www.rheumatologyadvisor.com/news/26-5-percent-of-adults-with-diabetes-used-glp-1-ra-injectables-in-2024/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: nebraskamed.com",
    "sourceUrl": "https://www.nebraskamed.com/health/healthy-lifestyle/bariatrics-weight-loss/what-you-need-to-know-about-the-compounded-glp-1",
    "summaryUrl": "https://www.nebraskamed.com/health/healthy-lifestyle/bariatrics-weight-loss/what-you-need-to-know-about-the-compounded-glp-1",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/18/health/glp1-muscle-loss-strength-training-wellness",
    "summaryUrl": "https://www.cnn.com/2025/08/18/health/glp1-muscle-loss-strength-training-wellness",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: qz.com",
    "sourceUrl": "https://qz.com/novo-nordisk-stock-pops-discount-ozempic-cash",
    "summaryUrl": "https://qz.com/novo-nordisk-stock-pops-discount-ozempic-cash",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: uknow.uky.edu",
    "sourceUrl": "http://uknow.uky.edu/uk-healthcare/new-generation-weight-loss-drugs-pros-and-cons-glp-1s",
    "summaryUrl": "http://uknow.uky.edu/uk-healthcare/new-generation-weight-loss-drugs-pros-and-cons-glp-1s",
    "date": "2025-08-26"
  },
  {
    "title": "MSN",
    "sourceUrl": "https://www.msn.com/en-us/health/other/staggeringly-high-discontinuation-rates-for-glp-1-drugs-like-ozempic-or-wegovy/ar-AA1uj3OS?apiversion=v2",
    "summaryUrl": "https://www.msn.com/en-us/health/other/staggeringly-high-discontinuation-rates-for-glp-1-drugs-like-ozempic-or-wegovy/ar-AA1uj3OS?apiversion=v2",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/eli-lilly-raising-glp-1-prices-abroad-raises-more-questions-about-us-pricing-bofa-analyst-191601993.html",
    "summaryUrl": "https://finance.yahoo.com/news/eli-lilly-raising-glp-1-prices-abroad-raises-more-questions-about-us-pricing-bofa-analyst-191601993.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: everydayhealth.com",
    "sourceUrl": "https://www.everydayhealth.com/weight-management/fda-raises-safety-concerns-with-compounded-glp-1-weight-loss-drugs/",
    "summaryUrl": "https://www.everydayhealth.com/weight-management/fda-raises-safety-concerns-with-compounded-glp-1-weight-loss-drugs/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: theguardian.com",
    "sourceUrl": "https://www.theguardian.com/business/2025/aug/14/eli-lilly-uk-price-weight-loss-jab-mounjaro-trump",
    "summaryUrl": "https://www.theguardian.com/business/2025/aug/14/eli-lilly-uk-price-weight-loss-jab-mounjaro-trump",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: gastroenterologyadvisor.com",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/study-ids-barriers-to-glp-1-receptor-agonist-use-in-adolescents-young-adults/",
    "summaryUrl": "https://www.gastroenterologyadvisor.com/news/study-ids-barriers-to-glp-1-receptor-agonist-use-in-adolescents-young-adults/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: m.facebook.com",
    "sourceUrl": "https://m.facebook.com/JuliaSamuelMBE/videos/the-truth-behind-body-image-and-quick-fixes-ozempic-mounjaro-they-promise-the-bo/1057939986368656/",
    "summaryUrl": "https://m.facebook.com/JuliaSamuelMBE/videos/the-truth-behind-body-image-and-quick-fixes-ozempic-mounjaro-they-promise-the-bo/1057939986368656/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicalnewstoday.com",
    "sourceUrl": "https://www.medicalnewstoday.com/articles/glp-1-microdosing-for-weight-loss-experts-weigh-the-pros-and-cons",
    "summaryUrl": "https://www.medicalnewstoday.com/articles/glp-1-microdosing-for-weight-loss-experts-weigh-the-pros-and-cons",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: everydayhealth.com",
    "sourceUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "summaryUrl": "https://www.everydayhealth.com/obesity/glp-1-pill-helps-people-with-obesity-lose-thirty-pounds-in-new-trial/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: chiefhealthcareexecutive.com",
    "sourceUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "summaryUrl": "https://www.chiefhealthcareexecutive.com/view/glp-1-drugs-and-those-who-take-them-che-explainer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rollingstone.com",
    "sourceUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "summaryUrl": "https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: ift.org",
    "sourceUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "summaryUrl": "https://www.ift.org/news-and-publications/blog/2025/smarter-nutrition-in-the-age-of-glp-1s",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abdpost.com",
    "sourceUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "summaryUrl": "https://www.abdpost.com/travis-barkers-ex-shanna-moakler-flaunts-mounjaro-weight-loss/399095",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: abcnews.go.com",
    "sourceUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "summaryUrl": "https://abcnews.go.com/GMA/Wellness/daily-oral-glp-1-pill-effective-weekly-shots/story?id=124440685",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnn.com",
    "sourceUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "summaryUrl": "https://www.cnn.com/2025/08/07/health/lilly-glp1-pill-weight-loss",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: fiercebiotech.com",
    "sourceUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "summaryUrl": "https://www.fiercebiotech.com/biotech/pfizers-embattled-obesity-program-loses-another-glp-1-drug",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicine.yale.edu",
    "sourceUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "summaryUrl": "https://medicine.yale.edu/news-article/new-research-letter-examines-glp-1-access-for-adolescents-and-young-adults/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: bbc.com",
    "sourceUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "summaryUrl": "https://www.bbc.com/news/articles/cwy3jg20j1ro",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: medicaldialogues.in",
    "sourceUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "summaryUrl": "https://medicaldialogues.in/amp/cardiology-ctvs/news/cardiac-safety-data-of-tirzepatide-released-tirzepatide-offers-additional-cardiac-benefits-over-dulaglutide-in-surpass-cvot-trial-152904",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: nutritioninsight.com",
    "sourceUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "summaryUrl": "https://www.nutritioninsight.com/news/gut-bacteria-glp-1-fat-loss-blood-sugar",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thehill.com",
    "sourceUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "summaryUrl": "https://thehill.com/policy/healthcare/5433642-americans-awareness-weight-loss-drugs-ozempic-wegovy-survey/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: hsph.harvard.edu",
    "sourceUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "summaryUrl": "https://hsph.harvard.edu/news/ozempic-wegovy-inspire-wave-of-glp-1-supplements-but-are-they-safe-or-effective/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: statnews.com",
    "sourceUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "summaryUrl": "https://www.statnews.com/2025/08/01/glp-1s-weight-loss-medication-ozempic-access-cost-medicare-medicaid/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investor.lilly.com",
    "sourceUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "summaryUrl": "https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thebody.com",
    "sourceUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "summaryUrl": "https://www.thebody.com/hiv/glp1-inhibitors-hiv-what-you-need-to-know",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: investors.hims.com",
    "sourceUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "summaryUrl": "https://investors.hims.com/news/news-details/2025/Hims--Hers-Data-Shows-Personalized-GLP-1-Plans-Drive-Real-Weight-Loss-Few-Side-Effects-and-Strong-Adherence-to-Care/default.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thecardiologyadvisor.com",
    "sourceUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "summaryUrl": "https://www.thecardiologyadvisor.com/news/tirzepatide-slows-kidney-decline-in-prediabetes-with-overweight-obesity/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "summaryUrl": "https://www.renalandurologynews.com/news/cancer-diabetes-t2dm-glp-1ra-improved-survival-patients/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news.cuanschutz.edu",
    "sourceUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "summaryUrl": "https://news.cuanschutz.edu/cancer-center/glp-1-drugs-thyroid-cancer",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: finance.yahoo.com",
    "sourceUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "summaryUrl": "https://finance.yahoo.com/news/could-glp-1-drugs-potentially-131600282.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: livemint.com",
    "sourceUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "summaryUrl": "https://www.livemint.com/opinion/online-views/ozempic-mounjaro-semaglutide-tirzepatide-appetite-suppression-weight-loss-culture-food-addiction-soylent-exercise-health-11753364865668.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: renalandurologynews.com",
    "sourceUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "summaryUrl": "https://www.renalandurologynews.com/news/glp-1-receptor-agonists-may-improve-outcomes-in-idiopathic-intracranial-hypertension/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: reddit.com",
    "sourceUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "summaryUrl": "https://www.reddit.com/r/Zepbound/comments/1m8r1cv/zepbound_vs_mounjaro/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: mercer.com",
    "sourceUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "summaryUrl": "https://www.mercer.com/en-us/insights/us-health-news/glp-1-considerations-for-2026-your-questions-answered/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: news-medical.net",
    "sourceUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "summaryUrl": "https://www.news-medical.net/news/20250723/What-happens-to-your-weight-after-quitting-GLP-1-anti-obesity-drugs.aspx",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: gastroenterologyadvisor.com",
    "sourceUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "summaryUrl": "https://www.gastroenterologyadvisor.com/news/glp-1-receptor-agonist-use-in-t2d-linked-to-increased-risk-for-gerd-gerd-complications/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: newsroom.uvahealth.com",
    "sourceUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "summaryUrl": "https://newsroom.uvahealth.com/2025/07/21/glp-1-drugs-fail-to-provide-key-weight-loss-benefit/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "summaryUrl": "https://www.cureus.com/articles/390268-effects-of-tirzepatide-on-low-density-lipoprotein-cholesterol-levels-in-adults-a-systematic-review",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cnbc.com",
    "sourceUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "summaryUrl": "https://www.cnbc.com/2025/07/20/weight-loss-drugs-could-help-treat-pcos.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: cureus.com",
    "sourceUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "summaryUrl": "https://www.cureus.com/articles/380767-weight-loss-that-lasts-reviewing-the-long-term-impact-of-glp-1-receptor-agonists",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: rheumatologyadvisor.com",
    "sourceUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "summaryUrl": "https://www.rheumatologyadvisor.com/news/certain-factors-may-predict-weight-fluctuations-after-glp-1-receptor-agonist-treatment/",
    "date": "2025-08-26"
  },
  {
    "title": "nejmJW_1L_RGB-b",
    "sourceUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "summaryUrl": "https://www.jwatch.org/na58926/2025/07/15/new-variations-glp-1-receptor-agonists-are-coming",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: dailymail.co.uk",
    "sourceUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "summaryUrl": "https://www.dailymail.co.uk/health/article-14910243/Scientists-discover-new-link-Mounjaro-BREAST-cancer.html",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: thelancet.com",
    "sourceUrl": "https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00197-4/fulltext?rss=yes",
    "summaryUrl": "https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00197-4/fulltext?rss=yes",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: empr.com",
    "sourceUrl": "https://www.empr.com/news/endo-superior-weight-loss-seen-with-tirzepatide-and-menopausal-hormone-therapy-use/",
    "summaryUrl": "https://www.empr.com/news/endo-superior-weight-loss-seen-with-tirzepatide-and-menopausal-hormone-therapy-use/",
    "date": "2025-08-26"
  },
  {
    "title": "Odkaz: pharmacytimes.com",
    "sourceUrl": "https://www.pharmacytimes.com/view/obesity-messaging-glp-1-agonists-and-the-pharmacist-s-ethical-imperative-navigating-a-shifting-landscape",
    "summaryUrl": "https://www.pharmacytimes.com/view/obesity-messaging-glp-1-agonists-and-the-pharmacist-s-ethical-imperative-navigating-a-shifting-landscape",
    "date": "2025-08-26"
  }
]